Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTRA1 | Q92743 | 6/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.39 |
| ▸ | NOS3 | P29474 | 5/20 | 0.39 |
| ▸ | NOS1 | P29475 | 5/20 | 0.39 |
| ▸ | NOS2 | P35228 | 5/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.37 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7324511 | 0.89 | MMP2 (0.42) | HTRA1NOS3NOS1NOS2MEN1 | |
| Trifluoroacetic Acid SCHEMBL7321835 | 0.89 | MMP2 (0.42) | HTRA1NOS3NOS1NOS2MEN1 | |
| Trifluoroacetic Acid SCHEMBL7317296 | 0.89 | MMP2 (0.42) | HTRA1NOS3NOS1NOS2MEN1 | |
| Trifluoroacetic Acid SCHEMBL7326606 | 0.89 | HTRA1 (0.43) | HTRA1NOS3NOS1NOS2MEN1 | |
| SCHEMBL7326943 | 0.83 | MMP2 (0.44) | HTRA1ITGB3ITGA2BNOS3NOS1 | |
| SCHEMBL7326842 | 0.83 | MMP2 (0.44) | HTRA1ITGB3ITGA2BNOS3NOS1 | |
| SCHEMBL7316571 | 0.83 | MMP2 (0.44) | HTRA1ITGB3ITGA2BNOS3NOS1 | |
| Trifluoroacetic Acid SCHEMBL7321899 | 0.83 | HTRA1 (0.41) | HTRA1NOS2MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL7321339 | 0.81 | CTSB (0.41) | HTRA1 | |
| SCHEMBL9724536 | 0.81 | TDP1 (0.51) | HTRA1NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0584066-A4 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES. | RHONE POULENC RORER INT (US) | 1994-10-12 | — | — | EP | claimed |
| EP-0584066-A1 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-03-02 | — | — | EP | claimed |
| WO-1992018117-A1 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0584066-A4 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES. | RHONE POULENC RORER INT (US) | 1994-10-12 | — | — | EP | disclosed |
| EP-0584066-A1 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1992018117-A1 | ANTI-THROMBOTIC PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-10-29 | — | — | WO | disclosed |